Follow us for updates
© 2022
Read the Story →

COVID-19 Vaccine Likely Available to the Public by Second Quarter of 2021: Official

If all goes well, the DOST estimates we can get it by May or June 2021.
by Clara Rosales
Aug 19, 2020
Photo/s: National Cancer Institute / Unsplash

A COVID-19 vaccine could be available to the public by the second quarter of next year, according to one of the officials in charge of clinical trials. Several vaccine candidates are being considered to determine which will best fit the country.

Human trials are scheduled in the fourth quarter, said Science and Technology Usec Rowena Guevarra. "If we are talking about availability en masse, we believe this is going to be happening in the 2nd quarter of next year," she said.

Vaccine makers are expected to submit findings on the trials as early as April next year, said Jaime Montoya, Executive Director of the DOST Philippine Council for Health Research Development.

See Also

Infectious disease expert Nina Gloriani, head of the Philippines' COVID-19 vaccine panel, said the country was in talks with the following developers: 

  • Sinovac (China)
  • Sinopharm (China)
  • University of Oxford (United Kingdom)
  • Moderna (United States)
  • Pfizer (United States)

All are already undergoing Phase 3 of trials—the last step before a vaccine can be approved and mass produced. Gloriani said the search panel got limited information on Russia's Sputnik V, which needs further study before local clinical trials commence.

Continue reading below ↓

See Also

Officials earlier said the Philippines would participate in Phase 3 of the Russia-developed vaccine. President Rodrigo Duterte claimed he would try out the vaccine first to ensure that it's safe for Filipinos to use.

More from reportrworld

Continue reading below ↓
Recommended Videos
Latest Headlines
more about:
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.